Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Circassia
Biotech
Woodford cut down as fund chopped and burned
After being hailed as a near mystic when it came to stock picks, Britain’s once great oak has been cut down to a sapling as Neil Woodford gets the ax.
Ben Adams
Oct 15, 2019 9:10am
British biotech startups get cash haul, major research windfall
May 20, 2019 4:38am
4 years after mega IPO, Circassia set for small-cap exchange
Dec 11, 2018 8:20am
Circassia defends allergy flops as business reboot continues
Apr 25, 2017 9:18am
Circassia scraps allergy program after another trial flops
Apr 18, 2017 2:43am
Circassia sinks as key allergy drug fails PhIII, pipeline under pressure
Jun 20, 2016 7:22am